Plain-English translation of NCT07778316 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called for people with a type of lung cancer called small cell lung cancer that has come back after their first round of chemotherapy. Researchers want to compare two ways of giving this medication: as an injection under the skin versus as an IV infusion into a vein. The goal is to see if the injection form works just as well as the IV form and is easier for patients to use.
Small cell lung cancer is aggressive and often comes back even after initial treatment. This medication offers a new approach that may help people whose cancer has progressed, and the injection form could make treatment more convenient by avoiding the need for frequent IV visits.
You likely qualify if…
You likely don't qualify if…
If you qualify and are selected, you will be randomly assigned to receive either the injection form or the IV infusion form of the medication. You will attend regular clinic visits where your health will be monitored, scans will be taken to check how your cancer is responding, and blood tests will be done. The study involves about 400 people across multiple hospitals, and your participation will help researchers understand whether the easier injection form is just as effective as the IV version for treating this type of cancer.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
United States
Australia
China